Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Lars Lindholm's publication output changed over time?
ScholarIQpublication output · 1991–2021
Output grew100% over the shown period — from 1 works in 1991 to 2 in 2021.
1
2
1
2
1
1
2
2
19911999200020022005200620132021
What are the most-cited papers on Lars Lindholm?
ScholarIQmost cited works
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel
The Lancet. 20025,421 Citations
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Authors/Task Force Members:, G. Mancia, Guy De Backer, Anna F. Dominiczak, Renata Cífková, R. Fagard, Giuseppe Germanò, Guıdo Grassı, A. M. Heagerty, SE Kjeldsen, S. Laurent, Krzysztof Narkiewicz, Luís M. Ruilope, Andrzej Rynkiewicz, Roland E. Schmieder, Harry A.J. Struijker Boudier, Alberto Zanchetti, Alec Vahanian, A. John Camm, Raffaele De Caterina, V. Dean, Kenneth Dickstein, G. Filippatos, Christian Funck‐Brentano, Irene Hellemans, S. D. Kristensen, Keith McGregor, U Sechtem, Sigmund Silber, Michał Tendera, P. Widimsky, José Luis Zamorano, SE Kjeldsen, Serap Erdine, Krzysztof Narkiewicz, W. Kiowski, Enrico Agabiti‐Rosei, E Ambrosioni, Renata Cífková, Anna F. Dominiczak, R. Fagard, A. M. Heagerty, S. Laurent, Lars Lindholm, G. Mancia, Athanasios Manolis, Peter M. Nilsson, Josep Redón, Roland E. Schmieder, Harry A.J. Struijker-Boudier, Margus Viigimaa, Document Reviewers:, G. Filippatos, Stamatis Adamopoulos, Enrico Agabiti‐Rosei, E Ambrosioni, Vicente Bertoméu, D Clément, Serap Erdine, Csaba Farsang, D. Gaita, W. Kiowski, Gregory Y.H. Lip, Jean-Michel Mallion, Athanasios Manolis, Peter M. Nilsson, Eoin O’Brien, Piotr Ponikowski, Josep Redón, Frank Ruschitzka, Juan Tamargo, PA van Zwieten, Margus Viigimaa, Bernard Waeber, Bryan Williams, José Luis Zamorano
European Heart Journal. 20062,390 CitationsOPEN ACCESS
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
Lennart Hansson, Lars Lindholm, Leo Niskanen, Jan Lanke, Thomas Hedner, Anders Niklason, K Luomanmäki, Björn Dahlöf, Ulf dé Fairé, Claes Mörlin, Bengt E. Karlberg, P-O Wester, Jan-Erik Björck
The Lancet. 19992,015 Citations
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
Björn Dahlöf, L. Hansson, Lars Lindholm, Bengt Scherstén, Tord Ekbom, P-O Wester
The Lancet. 19911,893 Citations
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Lars Lindholm, Hans Ibsen, Björn Dahlöf, Richard B. Devereux, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Stevo Julius, Sverre E. Kjeldsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Peter Aurup, Jonathan M. Edelman, Steven Snapinn
The Lancet. 20021,571 Citations
Related on ScholarIQ
Umeå University
Institution
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Paper
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Paper
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
Paper
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
Paper
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Paper